Abstract: Virtual trials have proved useful in developing safe and efficacious glycaemic control protocols. However, these trials rely on lumping all changes in patient condition into the insulin sensitivity parameter. As electronic data collection provides higher temporal resolution than paper-based charts, irregular timings of both therapies and measurements clash with a regular, hourly insulin sensitivity profile. Additionally, unobservable endogenous changes are a factor for hour-to-hour variability. This research extends the virtual trial protocol to natively handle irregular data by regularising the insulin sensitivity profile, and utilising a simple stochastic differential equation. The insulin sensitivity profile was re-interpreted as a b-spline basis, allowing a higher order description with greater local support. The fitting error resulting from this regularisation was absorbed by a stochastic element in the glucose compartment, representing the hour-to-hour changes that cannot be attributed to changes in insulin sensitivity. The resulting virtual patients were demonstrated to be equivalent to the originals when a 0 th order basis was used. Inclusion of the stochastic element in this case simply ensured the model still fitted during periods of unmodelled high endogenous glucose production, while a 2 nd order basis uses this element to natively control the balance between changes in patient state and hour-to-hour unmodelled changes due to noise and endogenous processes. The resulting virtual trials are thus better able to preserve information in irregular data sets, and regulate the balance between controllable and uncontrollable glycaemic changes.
INTRODUCTION
Virtual trials [Chase et al., 2010] are a valuable tool for in-silico development of control algorithms. However, validity of this methodology relies heavily on how model parameters are identified. Chase et al. describe a rigid parameter identification procedure that is not readily generalisable to more irregular data. This research describes a robust parameter identification and simulation procedure that features continuous parameter variation and native inclusion of internal noise.
Virtual trials were a key technique used to develop the STAR (Stochastic Targeted [Fisk et al., 2012] ) and SPRINT (Specialised Relative Insulin and Nutrition Tables [Chase et al., 2008] ) protocols in-silico. Avoiding physical trials during initial development enabled pre-informed protocols to be implemented in pilot studies, with the virtual trial results giving a high degree of confidence in safety and efficacy. Virtual trials also provide context analysing clinical trial results, as shown in [Chase et al., 2010 ]. An indicative measure of compliance and performance can be provided by the comparison between virtual trial results and true observations. Virtual trials are thus an valuable tool for model-based control design.
The key steps in a virtual trial are: A) fitting the underlying "true" parameter profile, B) using a protocol to choose the new treatment, and C) using the "true" parameter profile to solve for the resulting virtual blood glucose (BG) measurement. Correctly fitting the data is the critical step for a representative virtual trial, as failure to fit translates directly to loss of information and lesser virtual trial confidence. Due to low data density in a real-world glycaemic control setting only one parameter, insulin sensitivity, can be reliably identified.
Prior research developed the virtual trial methodology using the ICING (Intensive Control Insulin-NutritionGlucose ) model and integral-based fitting [Hann et al., 2005] . The available data was from SPRINT [Chase et al., 2008] in a summary spreadsheet with hourly slots for measurements leading to hourlybinned data. Consequently, fitting was carried out with an hourly piecewise-constant insulin sensitivity (S I ) profile, and linear interpolation to create intermediate BG estimates for 2-hourly intervals.
Implementation of the STAR protocol on a computerised tablet led to more precise timestamps recorded for measurements and therapy. With BG measurement times often offset from the hour, and nutrition changes happening between measurements, the use of piecewise-constant S I and interpolated measurements introduced new difficulties in creating virtual trials. A more physiological description of S I was deemed possible and desirable.
It is possible to address the concerns created by the nature of the irregularly dataset by modifying the virtual trial approach. In this work, the S I profile was made into a continuous function, and the error introduced regularising S I was captured in an additional term appended to the ICING model. The glucose model was thus converted to a novel, simplistic stochastic differential equation (SDE [Van Kampen, 1976] ).
METHODS

ICING model
The ICING model defines glucose and insulin kinetics and dynamics in critically ill patients: 
Parameter Identification
A simple version of the integral-based fitting method will be introduced via a differential equation with an unknown linear parameter, θ:
where x is the conserved quantity, θ the unknown constant parameter, f 1 (t, x) is the function corresponding to this parameter, and f 0 (t, x) contains the remaining known parameters and functions. The model estimate of x at time t is:
Assuming multiple data points, a residual error ( ) will occur. The error at the i th measurement, i = x mod (t i ) − x(t i ), is: which, provided the integrals can be numerically estimated, can be minimised using least squares for n measurements:
If measured data is dense enough, or appropriate assumptions used, these integrals can be fully formed without further computation, and the linear system solved directly [Hann et al., 2005] . If sparse data or noise causes these integrals to be poorly approximated by the available data, this approach can be applied iteratively, where new parameters produce a modified solution, which is then used to update the integrals [Docherty et al., 2012] .
As SPRINT data consisted of intermittent 1 and 2 hour measurement intervals, a distinct parameter value was fitted for each hour interval. Thus, θ was described as m piecewise-constant functions, where:
where γ j is the j th θ value and g j (t) is a rectangle function, non-zero on a single hour interval. This description of θ is equivalent to a 0 th order uniform b-spline basis [De Boor, 1972] with m + 1 knots, each an hour apart. Equation (7) thus expands to:
Accordingly, Equation (9) becomes:
whereΓ ( 
If m + 1 > n, the linear system is clearly indeterminate. Such a case almost always occurs with SPRINT data, as 2 hour BG measurements were common [Chase et al., 2008] . To circumvent this issue, SPRINT data was resampled hourly, an assumption that introduces fitting error if measurements are offset and can force unusual parameter spikes if additional glucose is added parenterally close to a re-sampled measurement. A continuous profile would therefore be beneficial, and controlling the order of the basis and knot locations provides a natural method for regularising the shape of the S I profile. However, using a knot at each measurement forces the shape of the S I profile to reach a maxima/minima in the middle of the measurement period, as well as forcing all changes to be the direct result of changes in S I .
S I profile
A distinction should be made in the use of this model for control and for virtual trials. In control, the model is refitted over a 6 hour period to ensure the initial conditions for the past hour are insensitive to modified data, and thus can be relied on for prediction. Previously, all dynamic changes were lumped into the S I profile. This raw S I profile showed a number of clinically important trends , Ferenci et al., 2013 highlighting the importance of S I . Clearly, the model-based metric evolves over time, and sudden rises greatly increase the risk of hypoglycaemia when patients are undergoing insulin therapy. Sudden increases in S I predispose patients to hypoglycaemia, as injected insulin has an amplified effect on BG, and insulin dose is selected based on the prior (reduced) effect of insulin.
Variability in S I exists due to changes in patient state, measurement noise, and mismodelled dynamics. Some literature suggests the major effect of intensive insulin therapy is the suppression of hepatic glucose production [Thorell et al., 2004] , though the relationship between plasma insulin and endogenous glucose production is poorly understood. Pulsatile delivery, intraportal concentrations, and arteriovenous concentration gradients are all thought to have an effect, amongst other factors. However, quantifying the relationship between the liver and insulin is impossible using the data available at the bedside in critical care. It is sufficient to say that the relationship changes, and thus not all changes in patient state can truly be labelled "insulin-dependent".
This research regularises the S I profile to restrict the frequency of "insulin-dependent" state changes by utilising the generalisable description of a b-spline [De Boor, 1972] basis. Figure 1 compares the current 0 th order basis with 60 minute knot widths with a proposed 2 nd order basis with 240 minute knot widths. A knot width of 240 minutes was chosen for the proposed description as 180 minutes is a typical measurement interval for STAR, and timing errors up to 60 minutes can occur. Thus, BG changes for between 1 to 3 measurement intervals are described by a single function. The local support provided by a 2 nd order description further regularises the profile.
Noise profile
Regularising the S I profile highlights a bias vs. variance tradeoff, as multiple measures per function introduces fitting error with real data. As the S I profile becomes smoother, greater error is introduced. Thus, additional fitting is required to prevent information being lost in the generation of virtual patients. Such information loss would result in virtual trials showing an artificial improvement. Returning to Equation (6), a zero-mean internal noise (process noise, φ(t)) can be added:
Typically, φ(t) would take the form of a wiener process. However, the added computational intensity associated with the increased resolution, and non-deterministic forward simulation, is not necessary in this application. In this simple SDE, φ(t) becomes the integral of a wiener process between two measurements, and captures unmodelled dynamics and measurement noise that cannot be incorporated by the now-regularised S I profile. Thus, φ(t) is a piecewise-constant function, individual values of which can be fitted using:
whereΦ (n,1) = [φ 1 , . . . , φ n ] (φ i is the i th value of the piecewise constant φ(t)), and: 
(17) As n + m > n when m > 0 this system is always rank-deficient. However, the definition of φ(t) as zeromean noise can be utilised to fill the rank of the system. As zero-mean noise, tn t0 φ(t)dt = 0, and by the definition of the basis functions,
As φ(t) is constant between two measurements:
Thus, the system in Equation (16) can be made full rank, and can be solved for all variables:
where:
The new form of the ICING model is therefore:
where S I (t) = θ(t) consists of b-spline basis functions, and G x (t) = φ(t) is the new stochastic element. During a virtual trial, G x (t) is treated as the observed realisation of the stochastic process, and used in conjunction with S I (t) to calculate deterministic outcomes to modified therapeutic inputs.
STAR Cohort
BG, insulin, and nutrition data was collected as part of routine use of the STAR protocol in Christchurch Hospital medical and surgical ICU between July 2011 and February 2013. For use in this study, datasets were split when a gap greater that 5 hours occurred between consecutive BG measurements. Observational ethics was granted by the National Ethics Advisory Committee (New Zealand). Available cohort details are shown in Table 2 .
Analyses
The intent of this research is to develop and implement a new fitting method to be used for virtual trials. Accordingly, two main categories of analyses were carried out. The first analysis was intended to demonstrate the problem solved by the research, and thus justify the added complexity. The second analysis was intended to give an understanding of the behaviour of the new methodology. For the iterative fits, convergence was assumed if maximum RMS error was within 0.1 mmol.L −1 (minimum resolution of a glucometer). To speed iterations, the G x profile was updated between iterations by using the current S I profile.
Initially, STAR data was fitted using the standard methodology yielding an hourly piecewise-constant S I profile fitted non-iteratively to linearly-interpolated hourly BG measurements. The fit was analysed with RMS error between BG measurements and modelled plasma glucose, to quantify how well a virtual trial would reproduce the original dataset. Fitting error in any patient indicates a virtual trial run using this patient could not recreate the original observed data, and thus error is an important metric.
The closest analogue of this method was then fitted using the basis function SDE approach. An hourly piecewiseconstant profile was not possible to fit without introducing further constraints, and so constant S I and G x values were fitted for each measurement interval using the presented methodology. RMS error in BG was presented for comparison with the original, and the G x distribution was presented as a cumulative density function (CDF). Finally, the regularised S I profile was fitted and error in BG was calculated.
The nature of the G x profile was then investigated graphically. The G x value for a measurement interval was plotted against the initial BG, time between measurements, mean exogenous glucose delivery (enteral and parenteral), and mean exogenous insulin. The contribution of G x to glucose disposal was also calculated. Figure 2 shows the dramatic reduction in fitting error when the SDE approach is used. No discernable difference is visible between the 0 th and 2 nd order basis functions. The difference between the two basis function shapes is shown in Figure 3 , where the 0 th order SDE forces G x → 0 except at extreme cases. The regularised basis of the 2 nd order SDE forces G x to absorb the remaining BG changes, hence producing a more variable G x profile. The method thus permits control over the contribution of noise to hourto-hour BG changes.
RESULTS
Dependence of the G x profile was investigated in Figure  4 . Graphically, the only factor that affects the variance of G x is measurement interval, which is congruent with the constraints on G x . Due to the choice of constraint, longer term changes in BG are mediated by S I , while short term changes predominantly affect the G x profile.
Finally, Figures 5 and 6 show the new methods implemented on the same patient and compared to the original. This patient was chosen as the episode includes an initial period of high BG that cannot be fitted by the original method, and has some minor interpolation artefacts near the end of the episode. Figure 5 shows the 0 th order basis has almost equivalent S I , barring some minor timing differences, and G x is zero everywhere except for the initial high BG period that is impossible to fit using the nonstochastic model. In comparison, the regularised basis used in Figure 6 has a much smoother S I profile, and where there are disparities between the original and new S I profiles G x is forced to be non-zero. S I is similar, and Gx is only non-zero when S I is constrained to the lower limit. S I is much smoother, and Gx is non-zero both when S I is constrained and when differences exist between the new and old profiles.
DISCUSSION
An updated fitting methodology is needed when using higher resolution data. An hourly S I value is useful for control, but timing errors cause information to be lost when creating virtual patients. During a virtual trial, this discrepancy means the original data cannot be created when the original inputs are used. Generalising S I to a series of b-spline basis functions permits timing errors to be natively captured, but introduces fitting error if the basis function local support extends beyond an individual measurement interval. To permit greater local support, and thus regularise the S I profile, a new time-varying parameter, G x , was introduced to eliminate fitting error. The methodology presented here is a robust way identify both of these parameters, where forcing G x to be zeromean allows the system to be fully defined, and the iterative integral method allows rapid solution.
Figure 2 demonstrates this approach solves the original problem. Fitting error can be forced to zero if enough iterations are carried out, and both the S I and G x profiles can be used in a virtual trial that fully recreates the data if the original intervals are used. As S I is regularised with a higher order basis, and wider knot widths, shorter-term changes cannot be captured by S I , instead being forced into the G x profile. This effect is seen in both Figure 3 and the example patient in Figures 5 and 6 . In this way, direct control can be exerted over the balance between changes in S I and observed noise.
This balance between noise and changes in S I may also be useful in control. Figure 4 shows a lack of dependence of noise on both exogenous inputs and current BG, showing only the expected dependence on measurement interval. This knowledge may be leveraged to improve model prediction. In particular, a continuous S I profile and a cohort G x profile could be used in a non-parametric prediction algorithm, replacing the computationally intensive stochastic model of STAR [Fisk et al., 2012] . Such a nonparametric approach could feasibly be updated in realtime, improving the quality of glycaemic control for longerstay ICU patients. Safety would be improved for more variable (higher noise) patients, and performance would be improved for more stable patients, neither of whom benefit from a whole-cohort approach. The novel simplicity of this SDE permits stable parameter identification with a relatively computationally light algorithm, which permits use in real-time glycaemic control.
One final possibility created by using this SDE approach is analysis of noise around changes in exogenous inputs. Patterns in the noise profile may possibly be used to identify areas where the model could be improved. For example, changes in nutrition rate may affect BG faster than the glucose absorption submodel permits, which will appear as positive G x values immediately after nutrition changes. Consistent patterns could be used to update parameter values either for an individual or for the wholecohort ICING model.
CONCLUSIONS
A robust parameter identification method was introduced, permitting identification of a smooth S I profile, and capturing remaining variation in a simple stochastic element, G x . This method suits the high resolution data available to STAR. Thus, future work will centre around implementation of a non-parametric prediction algorithm using these two parameters, allowing for direct inclusion into STAR.
